Description
The Enzo Life Sciences CNQX (6-Cyano-7-nitroquinoxaline-2,3-dione) is a potent and selective antagonist of AMPA and kainate receptors. This compound is supplied in a 5 mg dosage, identified by the MPN 550-042-M005. It is designed for research applications in neuroscience, particularly for studying excitatory neurotransmission and receptor function. Manufactured to high standards, this product ensures reliable performance in laboratory settings.
- Selective antagonist of AMPA and kainate receptors
- Supplied as 5 mg dosage
- Research grade compound
Explore the scientific potential of CNQX by adding it to your research toolkit today!





Reviews
There are no reviews yet.